Zdrowie i gospodarka · 30/12/1997

FDA Releases Preliminary Draft Guidance for In Vivo Bioequivalence Studies

The Food and Drug Administration (FDA) has made available a preliminary draft guidance for industry on performing in vivo bioequivalence studies using population and individual approaches, which could replace a prior guidance published in 1992.